Assistant Professor, Pathology, University of Texas Southwestern Medical Center, Southwestern Medical School
Pathology
Dr. Payal Kapur, MD
|
|
Give Review
Payal Kapur is an expert in the field of Pathology. She studied medicine at University of Texas Southwestern Medical School. Payal Kapur, MD is a published doctor as well. She has 50 publications published. The latest was: Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies. She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Light Reflectance Spectroscopy to Detect Positive Surgical Margins on Prostate Cancer Specimens.
- Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.
- Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
- Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy...
- Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
- Histologic upgrading in patients eligible for active surveillance on saturation biopsy.
- Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: Preliminary results.
- Role of fibroblast growth factor in squamous cell carcinoma of the bladder: Prognostic biomarker and potential therapeutic target.
- Evaluation of the prognostic significance of altered Mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
- Multi-Institutional Validation of the Predictive Value of KI-67 in Patients with High-Grade Urothelial Carcinoma of the Upper Urinary Tract.
- Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
- Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
- A Primary Melanoma and its Asynchronous Metastasis Highlight the Role of BRAF, CDKN2A, and TERT.
- Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.
- Utility of Biomarkers in the Prediction of Oncological Outcome after Radical Cystectomy for Squamous Cell Carcinoma.
- Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
- DOC-2/DAB2 Interacting Protein Status in High-Risk Prostate Cancer Correlates With Outcome for Patients Treated With Radiation Therapy.
- Prostate cancer detection using combined auto-fluorescence and light reflectance spectroscopy: ex vivo study of human prostates.
- Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
- Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: Results of a current series and a revie...
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
- Dysregulation of beta-catenin is an independent predictor of oncological outcomes in patients with clear cell renal cell carcinoma.
- GATA-3 Immunohistochemistry in the Differential Diagnosis of Adenocarcinoma of the Urinary Bladder.
- BAP1 immunohistochemistry in a multi-institutional cohort predicts outcomes in patients with clear cell renal cell carcinoma.
- Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract: is there evidence for discordant biology?
- Phospho-mTOR is not upregulated in metastatic SDHB paragangliomas.
- A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer.
- Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts.
- Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy.
- Ki-67 is an independent predictor of oncological outcomes in patients with high-grade upper tract urothelial carcinoma: results of a prospective analysis and a review ...
- Prognostic Role of Cell Cycle and Proliferative Biomarkers in Patients with Clear Cell Renal Cell Carcinoma.
- Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma.
- Rapid progression of a germ cell tumor encasing the inferior vena cava and aorta following a radical orchiectomy.
- The role of DAB2IP in androgen receptor activation during prostate cancer progression.
- Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy.
- Comparative Analysis of Oncologic Outcomes of Partial Ureterectomy vs Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
- Lymphovascular invasion in clear cell renal cell carcinoma-Association with disease-free and cancer-specific survival.
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.
- Cumulative Number of Altered Biomarkers in Mammalian Target of Rapamycin Pathway Is an Independent Predictor of Outcome in Patients With Clear Cell Renal Cell Carcinoma.
- Irreversible Electroporation: Evaluation of Nonthermal and Thermal Ablative Capabilities in the Porcine Kidney.
- DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
- Novel iron oxide microparticles used to render stone fragments paramagnetic: assessment of toxicity in a murine model.
- Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
- Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer.
- BAP1 loss defines a new class of renal cell carcinoma.
- A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.
- Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer.
- A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.
- Vulvar fibroadenoma with lactational changes in ectopic breast tissue.
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Texas Southwestern Medical School -
Delhi University College of Medical Sciences
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881763498 |
| Last Name Of The Provider | KAPUR |
| First Name Of The Provider | PAYAL |
| View All |
Similar Doctors
|
|
Dr. Scott B. Shappell, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. George J. Snipes Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret E. Bell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramiah Subramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Watkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Celeste J. Vardaman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Voet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara A. Shinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacia E. Clement-Kruzel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Meyerson, MD
This Doctor is OpenDoctor Recommended.
|